About us

AstraZeneca is one of the world's leading pharmaceutical companies, formed in 1999 following the merger of Astra AB and Zeneca group PLC. We provide innovative, effective prescription medicines in several important areas of medical need: gastrointestinal, cardiovascular, oncology, neuroscience, anesthesia, infection, respiratory & inflammation. Many of our products are world leaders.

Our corporate headquarters are in London UK and our R&D headquarters in Sodertalje, Sweden. Our products are available in over 100 countries and the healthcare sales in 2008 totaled $31. 6 billion.

AstraZeneca has a strong research base. We spent more than $5 billion on the research and development of new medicines yearly that meet patient needs. We employ 12,000 people in research and development at 17 R&D centres in 8 countries.

We have a promising early development pipeline showing significant progress. Please visit our global website for the full, updated pipeline summary.

We have 26 manufacturing sites all over the world dedicated to ensuring we can deliver a secure, high quality, cost-effective supply of our product range around the world.
 
In total, we employ over 65,000 people worldwide in the research, development, manufacturing and marketing of pharmaceuticals and the supply of healthcare services.

AstraZeneca is listed in the Dow Jones Sustainability Index (Global) and the FTSE4Good Index.